arrow
J

John K. Lin

university of texas system
H指数:20
被引数:4.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo)

一项多中心随机II期试验,比较仑伐替尼联合依维莫司与卡博替尼在PD-1免疫检查点抑制剂进展后的转移性透明细胞肾细胞癌患者中的疗效(LenCabo)。

2025-10-180
PRE
20Phase II trial of ivonescimab in patients with advanced clear cell renal cell carcinoma previously treated with immune checkpoint blockade: IVORY trial (NCT06940518)

II期临床试验:评估ivonescimab在既往接受过免疫检查点阻断治疗的晚期透明细胞肾细胞癌患者中的疗效(IVORY试验,NCT06940518)。

2025-10-010
OAAI
Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer

生物力学ct对转移性激素敏感型前列腺癌骨折风险分级的验证

2024-08-011
OA
The State of US Health, 1990-2010 Burden of Diseases, Injuries, and Risk Factors

美国健康状况,1990 2010的疾病负担,伤害和危险因素

2013-08-142.1K
OA